fingolimod hydrochloride has been researched along with imatinib mesylate in 2 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (imatinib mesylate) | Trials (imatinib mesylate) | Recent Studies (post-2010) (imatinib mesylate) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 11,477 | 960 | 5,773 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | imatinib mesylate (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.31 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaser, BW; Bloomfield, CD; Byrd, JC; Caligiuri, MA; Chen, CS; Cortes, J; Druker, BJ; Eiring, AM; Gambacorti-Passerini, C; Liu, S; Marcucci, G; Muthusamy, N; Neviani, P; Notari, M; Oaks, JJ; Perrotti, D; Roy, DC; Santhanam, R; Trotta, R; Verrills, NM | 1 |
| Baer, K; Frevert, U; Kappe, SH; Mikolajczak, SA; Movila, A; Nacer, A | 1 |
2 other study(ies) available for fingolimod hydrochloride and imatinib mesylate
| Article | Year |
|---|---|
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
Topics: Animals; Benzamides; Blast Crisis; Cell Survival; Dasatinib; Drug Resistance, Neoplasm; Fingolimod Hydrochloride; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Molecular Structure; Phosphoprotein Phosphatases; Phosphorylation; Piperazines; Propylene Glycols; Protein Phosphatase 2; Pyrimidines; Signal Transduction; Sphingosine; Thiazoles; Time Factors; Tumor Cells, Cultured | 2007 |
Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
Topics: Animals; Benzamides; Blood-Brain Barrier; Cerebral Hemorrhage; Disease Models, Animal; Fingolimod Hydrochloride; Imatinib Mesylate; Lipopolysaccharide Receptors; Lymphocyte Function-Associated Antigen-1; Malaria, Cerebral; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Neuroimmunomodulation; Parasitemia; Piperazines; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Propylene Glycols; Pyrimidines; Sphingosine | 2012 |